Lisa Rojkjaer
2021
In 2021, Lisa Rojkjaer earned a total compensation of $1.8M as Chief Medical Officer at Sunesis Pharmaceuticals, a 119% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $171,834 |
|---|---|
| Option Awards | $918,963 |
| Salary | $439,833 |
| Stock Awards | $236,054 |
| Other | $9,652 |
| Total | $1,776,336 |
Rojkjaer received $919K in option awards, accounting for 52% of the total pay in 2021.
Rojkjaer also received $171.8K in non-equity incentive plan, $439.8K in salary, $236.1K in stock awards and $9.7K in other compensation.
Rankings
In 2021, Lisa Rojkjaer's compensation ranked 6,518th out of 12,415 executives tracked by ExecPay. In other words, Rojkjaer earned more than 47.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,518 out of 12,415 | 48th |
Division Manufacturing | 2,799 out of 5,508 | 49th |
Major group Chemicals And Allied Products | 1,235 out of 2,378 | 48th |
Industry group Drugs | 1,102 out of 2,099 | 48th |
Industry Pharmaceutical Preparations | 799 out of 1,549 | 48th |
Source: SEC filing on April 27, 2022.
Rojkjaer's colleagues
We found three more compensation records of executives who worked with Lisa Rojkjaer at Sunesis Pharmaceuticals in 2021.